Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative versus postoperative cisplatin + gemcitabine in resectable NSCLC
2006-002708-33Phase 3Terminated
- Sponsor
- Istituti Fisioterapici Ospitalieri
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gemcitabine and cisplatin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Istituti Fisioterapici Ospitalieri. Primary endpoint: Overall survival. Started Jul 2007; status: terminated.
02
Drugs
gemcitabinecisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2006-002708-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002708-33.